Get the Stockscreener App
67.91
1.04%
0.70
After Hours:
67.89
-0.02
-0.03%
Overview
News
Price History
Option Chain
Financials
Why ALC Down?
Discussions
Forecast
Dividend History
Alcon Inc stock is traded at $67.91, with a volume of 1.26M.
It is up +1.04% in the last 24 hours and down -0.03% over the past month.
Alcon is one of the leading visioncare companies in the world. Following nine years as a Novartis subsidiary, it was spun off as a public company in April 2019. Alcon operates in two segments: visioncare and surgical. Visioncare comprises contact lenses, lenscare solutions, and a suite of ocular health products. With brands like Dailies, Total1, and Air Optix, Alcon controls about one fourth of the US contact lens market. Surgical comprises intraocular lenses, ophthalmic surgical equipment, and consumables used during surgeries. Its main products include Centurion, a phacoemulsification device used during cataract surgeries, and a portfolio of IOLs including PanOptix and Vivity. Alcon has one of the largest installed bases of eye surgical equipment in the world.
See More
Previous Close:
$67.21
Open:
$67.64
24h Volume:
1.26M
Relative Volume:
0.58
Market Cap:
$33.12B
Revenue:
$10.63B
Net Income/Loss:
$819.00M
P/E Ratio:
40.97
EPS:
1.6577
Net Cash Flow:
$1.59B
1W Performance:
-3.34%
1M Performance:
-0.03%
6M Performance:
-15.42%
1Y Performance:
-26.10%
1-Day Range:
$67.42
$68.36
1-Week Range:
$66.17
$70.31
52-Week Range:
$61.84
$91.86
Alcon Inc Stock (ALC) Company Profile
Name
Alcon Inc
Sector
Industry
Phone
-
Address
-
Compare ALC vs ISRG, BDX, MDLN, RMD
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
ALC
Alcon Inc
|
67.91 | 32.78B | 10.63B | 819.00M | 1.59B | 1.6577 |
ISRG
Intuitive Surgical Inc
|
337.50 | 118.96B | 11.03B | 3.16B | 3.22B | 8.7251 |
BDX
Becton Dickinson Co
|
156.36 | 42.15B | 21.37B | 1.41B | 3.07B | 3.9437 |
MDLN
Medline Inc
|
38.75 | 31.82B | 29.14B | 1.07B | 1.05B | 1.1956 |
RMD
Resmed Inc
|
195.27 | 27.83B | 5.54B | 1.52B | 1.74B | 10.37 |
Alcon Inc Stock (ALC) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Feb-26-26 | Upgrade | Wells Fargo | Equal Weight → Overweight |
| Jan-30-26 | Initiated | William Blair | Mkt Perform |
| Jan-20-26 | Upgrade | Deutsche Bank | Hold → Buy |
| Jan-09-26 | Downgrade | Stifel | Buy → Hold |
| Dec-11-25 | Downgrade | BofA Securities | Buy → Underperform |
| Aug-21-25 | Downgrade | JP Morgan | Overweight → Neutral |
| May-20-25 | Downgrade | Deutsche Bank | Buy → Hold |
| May-14-25 | Reiterated | BTIG Research | Buy |
| Mar-28-25 | Reiterated | Needham | Buy |
| Mar-25-25 | Upgrade | BofA Securities | Neutral → Buy |
| Jan-24-25 | Reiterated | Needham | Buy |
| Jan-10-25 | Upgrade | Redburn Atlantic | Neutral → Buy |
| Dec-17-24 | Reiterated | Needham | Buy |
| Nov-12-24 | Reiterated | Needham | Buy |
| Oct-10-24 | Upgrade | Redburn Atlantic | Sell → Neutral |
| Sep-10-24 | Upgrade | RBC Capital Mkts | Sector Perform → Outperform |
| Jul-15-24 | Upgrade | Morgan Stanley | Underweight → Equal-Weight |
| May-15-24 | Upgrade | Oppenheimer | Perform → Outperform |
| Apr-10-24 | Initiated | Goldman | Buy |
| Mar-14-24 | Initiated | RBC Capital Mkts | Sector Perform |
| Feb-06-24 | Resumed | KeyBanc Capital Markets | Overweight |
| Jan-23-24 | Initiated | Bernstein | Outperform |
| Dec-18-23 | Downgrade | Redburn Atlantic | Neutral → Sell |
| Dec-12-23 | Initiated | Stifel | Buy |
| Dec-04-23 | Downgrade | Morgan Stanley | Equal-Weight → Underweight |
| Aug-17-23 | Upgrade | JP Morgan | Neutral → Overweight |
| May-30-23 | Resumed | Morgan Stanley | Equal-Weight |
| May-10-23 | Upgrade | Robert W. Baird | Neutral → Outperform |
| Mar-01-23 | Upgrade | Societe Generale | Sell → Hold |
| Dec-22-22 | Initiated | Mizuho | Buy |
| Nov-17-22 | Downgrade | Societe Generale | Hold → Sell |
| Aug-11-22 | Downgrade | Societe Generale | Buy → Hold |
| May-13-22 | Resumed | Credit Suisse | Outperform |
| May-12-22 | Upgrade | Stephens | Equal-Weight → Overweight |
| Apr-08-22 | Initiated | Needham | Buy |
| Mar-11-22 | Initiated | BofA Securities | Buy |
| Jan-18-22 | Downgrade | Stephens | Overweight → Equal-Weight |
| Jan-07-22 | Downgrade | Morgan Stanley | Overweight → Equal-Weight |
| Oct-01-21 | Initiated | Oppenheimer | Perform |
| Jul-14-21 | Initiated | Deutsche Bank | Buy |
| May-06-21 | Upgrade | Citigroup | Sell → Neutral |
| Mar-22-21 | Upgrade | BTIG Research | Neutral → Buy |
| Nov-12-20 | Downgrade | Guggenheim | Buy → Neutral |
| Jul-06-20 | Downgrade | Citigroup | Neutral → Sell |
| Jul-06-20 | Initiated | KeyBanc Capital Markets | Sector Weight |
| Jun-16-20 | Upgrade | Guggenheim | Neutral → Buy |
| Apr-08-20 | Downgrade | Robert W. Baird | Outperform → Neutral |
| Mar-26-20 | Upgrade | Argus | Hold → Buy |
| Mar-24-20 | Upgrade | Societe Generale | Sell → Hold |
| Mar-13-20 | Upgrade | UBS | Neutral → Buy |
| Mar-05-20 | Initiated | Citigroup | Neutral |
| Feb-26-20 | Upgrade | Berenberg | Hold → Buy |
| Jan-08-20 | Initiated | Argus | Hold |
| Oct-29-19 | Initiated | Stephens | Equal-Weight |
| Aug-21-19 | Reiterated | BofA/Merrill | Neutral |
| Jun-24-19 | Initiated | SVB Leerink | Mkt Perform |
| Jun-14-19 | Initiated | BTIG Research | Neutral |
| May-10-19 | Initiated | Robert W. Baird | Outperform |
| May-02-19 | Initiated | Credit Suisse | Outperform |
View All
Alcon Inc Stock (ALC) Latest News
Alcon stock holds steady as investors await fresh catalyst - AD HOC NEWS
Alcon | 7/24/26 - ktnv.com
Alcon gets you seeing in time for school - WSBT
Alcon: Back-to-School eye exams. What every parent should know. - KHGI
Alcon (ALC) Unveils Advanced Training Center for Vitreoretinal S - GuruFocus
Aravind Eye Care System and Alcon Launch Global Centre of Excellence for Retina Training in Coimbatore, India - PR Newswire
Alcon stock trades steady as eye care specialist builds on 2025 growth and higher margins - AD HOC NEWS
Systane Complete by Alcon Inc.dry eye relief built on oil-based drops - AD HOC NEWS
Alcon stock trades steadily as surgical eye care revenue grows - AD HOC NEWS
ALC stock trades steadily as Alcon lifts 2024 outlook on stronger surgical and vision care demand - Ad-hoc-news.de
Enterprise value to revenue forward of Alcon AG – SIX:ALC - TradingView
Alcon stock trades steadily as recent earnings highlight margin and growth mix - Ad-hoc-news.de
Alcon (SWX:ALC) Stock Looks Undervalued On Cash Flow But Fair On Earnings - Yahoo Finance
Alcon stock supported by steady growth and surgical demand - Ad-hoc-news.de
A Look at Alcon Inc (ALC) After 3.8% Decline -- GF Value $91.41 vs Price $67.35 - GuruFocus
ALC|Alcon AG|Price:67.210| - TradingKey
Alcon stock holds its ground as 2025 sales and profit metrics frame the 22 July 2026 setup - Ad-hoc-news.de
Sight Sciences wins $34M patent ruling against Alcon - MSN
The Systane Ultra Lubricant Eye Drops. Dry-eye care with a long shelf presence - Ad-hoc-news.de
Alcon stock trades steady as recent earnings highlight margin and growth dynamics - Ad-hoc-news.de
Alcon stock trades steadily as eye-care leader posts rising revenue and margins - Ad-hoc-news.de
Alcon stock steadies as surgical eye-care demand supports revenue growth - Ad-hoc-news.de
Alcon stock trades steadily as surgical vision business supports earnings - Ad-hoc-news.de
Alcon stock trades steadily as surgical eye-care growth supports earnings - Ad-hoc-news.de
Mexican Gold Mining Corp. and Alcon Silver Corp. Complete Arrangement to Create Platauro Metals Corp., a Diversified Precious Metals Exploration Company - TMX Newsfile
Alcon Inc. (ALC) Stock Analysis: Navigating 24.66% Potential Upside with Strong Buy Ratings - DirectorsTalk Interviews
Alcon stock trades steadily as surgical eye care growth supports earnings outlook - Ad-hoc-news.de
Price to book forward of Alcon AG – BX:2U3 - TradingView
Alcon stock trades steadily as eye-care demand supports revenue growth - Ad-hoc-news.de
Alcon stock trades near recent highs as surgical vision demand supports growth - Ad-hoc-news.de
Alcon stock trades steadily as eye care group highlights Q1 2026 growth and margins - Ad-hoc-news.de
Alcon stock trades steadily as eye care leader builds on solid revenue growth - Ad-hoc-news.de
Alcon stock steadies as investors weigh surgical vision growth and recent earnings trends - Ad-hoc-news.de
Alcon stock trades steady as eye-care margins support growth outlook - Ad-hoc-news.de
Alcon stock trades steadily as surgical eye care growth supports margins - ad-hoc-news.de
Systane Augentropfen by Alcon Inc.dry-eye relief built on medical data - ad-hoc-news.de
Alcon stock trades steady as vision care group focuses on margin and growth after 2025 earnings - Ad-hoc-news.de
Alcon stock trades steadily as surgical eye care growth supports recent earnings - ad-hoc-news.de
Alcon stock trades steady as latest earnings show margin resilience - ad-hoc-news.de
Mizuho Securities Maintains Alcon(ALC.US) With Buy Rating, Cuts Target Price to $80 - Moomoo
Alcon stock holds steady as eye-care demand supports the long-term growth story - ad-hoc-news.de
Systane Hydration by Alcon Inc.dry eye relief beyond the pharmacy shelf - ad-hoc-news.de
Alcon Inc (ALC) Shares Fall 3.1% -- What GF Score of 71 Tells In - GuruFocus
Alcon: From Reactive to Proactive with Centralized Regulatory Intelligence - Veeva
Alcon & RxSight Collaborate to Develop Adjustable PCIOL Technology - Zacks Investment Research
Systane Ultra Lubricant Eye Drops by Alcon Inc.dry-eye relief drives a global franchise - ad-hoc-news.de
Ophthalmology Devices Market Report Released, Includes - GlobeNewswire
Ophthalmology Devices Market Report Released, Includes Profiles of EssilorLuxottica, Alcon, Bausch + Lomb, and 20 Others - Yahoo Finance UK
Alcon stock reflects ophthalmic focus as global eye care demand grows - ad-hoc-news.de
Alcon collaborates with RxSight to develop adjustable PCIOLs - MSN
Alcon, RxSight announce collaboration to develop adjustable presbyopia-correcting IOLs - Ophthalmology Times Europe
Alcon Inc Stock (ALC) Financials Data
Revenue
Net Income
Cash Flow
EPS
2.98%
7.67%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):